Literature DB >> 19339044

Can the polypill save the world from heart disease?

Christopher P Cannon1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339044     DOI: 10.1016/S0140-6736(09)60652-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Polypill: lights and shadows.

Authors:  Koon K Teo; Yan Liang
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

2.  Understanding patients' experiences of treatment burden in chronic heart failure using normalization process theory.

Authors:  Katie Gallacher; Carl R May; Victor M Montori; Frances S Mair
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

Review 3.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

Review 4.  Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction.

Authors:  Thomas J Wang
Journal:  Circulation       Date:  2011-02-08       Impact factor: 29.690

5.  The United States and global health: inseparable and synergistic? The Institute of Medicine's report on global health.

Authors:  Mohammed K Ali; K M Venkat Narayan
Journal:  Glob Health Action       Date:  2009-10-29       Impact factor: 2.640

Review 6.  Secondary prevention strategies for coronary heart disease.

Authors:  Shepard D Weiner; LeRoy E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2010-01       Impact factor: 2.300

Review 7.  Uncovering treatment burden as a key concept for stroke care: a systematic review of qualitative research.

Authors:  Katie Gallacher; Deborah Morrison; Bhautesh Jani; Sara Macdonald; Carl R May; Victor M Montori; Patricia J Erwin; G David Batty; David T Eton; Peter Langhorne; Frances S Mair
Journal:  PLoS Med       Date:  2013-06-25       Impact factor: 11.069

Review 8.  Will cardiovascular disease prevention widen health inequalities?

Authors:  Simon Capewell; Hilary Graham
Journal:  PLoS Med       Date:  2010-08-24       Impact factor: 11.069

9.  Lipidomics reveals multiple pathway effects of a multi-components preparation on lipid biochemistry in ApoE*3Leiden.CETP mice.

Authors:  Heng Wei; Chunxiu Hu; Mei Wang; Anita M van den Hoek; Theo H Reijmers; Suzan Wopereis; Jildau Bouwman; Raymond Ramaker; Henrie A A J Korthout; Marco Vennik; Thomas Hankemeier; Louis M Havekes; Renger F Witkamp; Elwin R Verheij; Guowang Xu; Jan van der Greef
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

10.  Differences in primary health care delivery to Australia's Indigenous population: a template for use in economic evaluations.

Authors:  Katherine S Ong; Rob Carter; Margaret Kelaher; Ian Anderson
Journal:  BMC Health Serv Res       Date:  2012-09-07       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.